Search

Author/Creator Aronchik, Ida

1. Clinical activity of CC‐90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies. Issue 17 (23rd June 2022)

Authors:
Hollebecque, Antoine; Salvagni, Stefania; Plummer, Ruth; Niccoli, Patricia; Capdevila, Jaume; Curigliano, Giuseppe; Moreno, Victor; de Braud, Filippo; de Villambrosia, Sonia Gonzalez; Martin‐Romano, Patricia; Baudin, Eric; Arias, Marina; de Alvaro, Juan; Parra‐Palau, Josep L.; Sánchez‐Pérez, Tani...
Journal:
Cancer
Issue:
Volume 128:Issue 17(2022)
Page Start:
3185
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. CTNI-16. TROTABRESIB (CC-90010, BMS-986378), A REVERSIBLE, POTENT ORAL BROMODOMAIN AND EXTRATERMINAL INHIBITOR (BETi) IN PATIENTS WITH HIGH-GRADE GLIOMAS: A PHASE 1 OPEN-LABEL 'WINDOW OF OPPORTUNITY' STUDY. (12th November 2021)

Authors:
Vogelbaum, Michael; Sepulveda, Juan Manuel; Reardon, David; Hanna, Bishoy; Filvaroff, Ellen; Aronchik, Ida; Amoroso, Barbara; Zuraek, Marlene; Sanchez-Perez, Tania; Mendez, Cristina; Nikolova, Zariana; Moreno, Victor
Journal:
Neuro-oncology
Issue:
Volume 23: Supplement 6(2021)
Page Start:
vi62
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. CTNI-51. ADJUVANT TROTABRESIB, A REVERSIBLE POTENT BROMODOMAIN AND EXTRATERMINAL INHIBITOR, PLUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA: INTERIM RESULTS FROM A PHASE 1B DOSE-FINDING STUDY. (12th November 2021)

Authors:
Vieito, Maria; Simonelli, Matteo; de Vos, Filip; Moreno, Victor; Geurts, Marjolein; Lorenzi, Elena; Macchini, Marina; van den Bent, Martin; Del Conte, Gianluca; de Jonge, Maja; Amoroso, Barbara; Sanchez-Perez, Tania; Zuraek, Marlene; Hanna, Bishoy; Aronchik, Ida; Filvaroff, Ellen; Mendez, Cristin...
Journal:
Neuro-oncology
Issue:
Volume 23: Supplement 6(2021)
Page Start:
vi71
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma. Issue 1 (28th October 2022)

Authors:
Vieito, Maria; Simonelli, Matteo; de Vos, Filip; Moreno, Victor; Geurts, Marjolein; Lorenzi, Elena; Macchini, Marina; van den Bent, Martin J; Del Conte, Gianluca; de Jonge, Maja; Martín-Soberón, Maria Cruz; Amoroso, Barbara; Sanchez-Perez, Tania; Zuraek, Marlene; Hanna, Bishoy; Aronchik, Ida; Fil...
Journal:
Neuro-oncology advances
Issue:
Volume 4:Issue 1(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗